Brookings: mHealth Offers Solutions To Chinese Health Problems
This article was originally published in The Gray Sheet
Executive Summary
A Brookings Institution report makes the case for mobile Health as a partial solution to problems with health care delivery in China.
You may also be interested in...
Chinese Leadership Transitions, But Health Care Reforms Expected To Move Forward As Planned
“The Gray Sheet” interviewed four China experts on the occasion of the country’s leadership transition to gauge the impact of the change on ongoing health care reforms and device purchasing.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.